KMT2A and acute lymphoblastic leukemia: Using MLL-ALL patient-derived xenograft (PDX) models that we have previously reported [26], we found addition of RK-20449 to dexamethasone eliminated GC-resistant primary MLL-ALL cells in vivo in a majority of recipients engrafted with infant MLL-ALL.